|
82
|
297
|
6gubA |
Cdk2/cyclina in complex with flavopiridol |
|
86
|
297
|
6gu2A |
Cdk1/cyclinb/cks2 in complex with flavopiridol |
|
82
|
299
|
6gueA |
Cdk2/cyclina in complex with azd5438 |
|
84
|
300
|
6guhA |
Cdk2 in complex with azd5438 |
|
82
|
297
|
6gueC |
Cdk2/cyclina in complex with azd5438 |
|
81
|
292
|
6gu3A |
Cdk1/cyclinb/cks2 in complex with azd5438 |
|
78
|
292
|
6gu4A |
Cdk1/cyclinb/cks2 in complex with cgp74514a |
|
81
|
291
|
6gu6A |
Cdk1/cks2 in complex with dinaciclib |
|
79
|
298
|
6gukA |
Cdk2 in complex with cgp74514a |
|
82
|
297
|
6gucA |
Cdk2/cyclina in complex with su9516 |
|
83
|
299
|
6gufA |
Cdk2/cyclina in complex with cgp74514a |
|
94
|
323
|
6cytA |
Hiv-1 tar loop in complex with tat:aff4:p-tefb |
|
90
|
299
|
6q4jA |
Cdk2 in complex with fraglite34 |
|
87
|
296
|
6q4dA |
Cdk2 in complex with fraglite31 |
|
87
|
298
|
6q4aA |
Cdk2 in complex with fraglite14 |
|
84
|
296
|
6q48A |
Cdk2 in complex with fraglite7 |
|
83
|
297
|
6q3cA |
Cdk2 in complex with fraglite1 |
|
88
|
299
|
6q4hA |
Cdk2 in complex with fraglite36 |
|
86
|
300
|
6q4cA |
Cdk2 in complex with fraglite16 |
|
88
|
302
|
6q3fA |
Cdk2 in complex with fraglite2 |
|
84
|
298
|
6q3bA |
Cdk2 in complex with fraglite2 |
|
85
|
299
|
6q4eA |
Cdk2 in complex with fraglite33 |
|
84
|
298
|
6q4bA |
Cdk2 in complex with fraglite13 |
|
87
|
300
|
6q4fA |
Cdk2 in complex with fraglite32 |
|
83
|
299
|
6q4kA |
Cdk2 in complex with fraglite38 |
|
82
|
298
|
6q4iA |
Cdk2 in complex with fraglite35 |
|
88
|
298
|
6q49A |
Cdk2 in complex with fraglite6 |
|
82
|
298
|
6q4gA |
Cdk2 in complex with fraglite37 |
|
88
|
290
|
6gvaA |
Cdk2/cyclin a2 in complex with pyrazolo[4,3-d]pyrimidine inhibitor lgr4455 |
|
82
|
298
|
3unkA |
Cdk2 in complex with inhibitor yl5-083 |
|
75
|
298
|
3s0oA |
Cdk2 in complex with inhibitor rc-1-138 |
|
80
|
298
|
3s00A |
Cdk2 in complex with inhibitor l4-14 |
|
85
|
298
|
3sw7A |
Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor |
|
78
|
298
|
3s1hA |
Cdk2 in complex with inhibitor rc-2-39 |
|
89
|
301
|
5mhqA |
Cct068127 in complex with cdk2 |
|
82
|
292
|
5lqfA |
Cdk1/cyclinb1/cks2 in complex with nu6102 |
|
86
|
299
|
5lmkA |
Structure of phopsho-cdk2-cyclin a in complex with an atp-competitive inhibitor |
|
77
|
297
|
5lmkC |
Structure of phopsho-cdk2-cyclin a in complex with an atp-competitive inhibitor |
|
88
|
298
|
5l2wA |
The x-ray co-crystal structure of human cdk2/cycline and dinaciclib. |
|
68
|
292
|
5l2iA |
The x-ray co-crystal structure of human cdk6 and palbociclib. |
|
80
|
291
|
5l2sA |
The x-ray co-crystal structure of human cdk6 and abemaciclib. |
|
76
|
291
|
5l2tA |
The x-ray co-crystal structure of human cdk6 and ribociclib. |
|
83
|
299
|
5k4jA |
Crystal structure of cdk2 in complex with compound 22 |
|
77
|
296
|
5jq8A |
Crystal structure of cdk2 in complex with inhibitor icec0943 |
|
81
|
296
|
5jq5A |
Crystal structure of cdk2 in complex with inhibitor icec0942 |
|
79
|
298
|
5ievA |
Crystal structure of bay 1000394 (roniciclib) bound to cdk2 |
|
82
|
298
|
5ieyA |
Crystal structure of a cdk inhibitor bound to cdk2 |
|
84
|
298
|
5if1A |
Crystal structure apo cdk2/cyclin a |
|
85
|
298
|
5iexA |
Crystal structure of (r,s)-s-{4-[(5-bromo-4-{[(2r,3r)-2-hydroxy-1-methylpropyl]oxy}- pyrimidin-2-yl)amino]phenyl}-s-cyclopropylsulfoximide bound to cdk2 |
|
102
|
363
|
5idnA |
Cdk8-cycc in complex with [(s)-2-(4-chloro-phenyl)-pyrrolidin-1-yl]-(3-methyl-1h-pyrazolo[3,4-b]pyridin-5-yl)-methanone |
